AGT and triple-A syndrome: In the previous report, 0.05 mg/kg per day of ONO‐AE3‐208, an EP4 antagonist, decreased aortic aneurysm formation in angiotensin II‐ and CaCl2‐induced mouse AAA (Yokoyama et al.